Jaques Reifman Selected Research

Jaques Reifman Research Topics

Disease

9	Wounds and Injuries (Trauma) 01/2020 - 02/2011
7	Sleep Deprivation 01/2022 - 11/2012
6	Infections 01/2022 - 11/2010
4	Malaria 01/2022 - 09/2014
4	Inflammation (Inflammations) 01/2019 - 02/2014
3	Thrombosis (Thrombus) 01/2020 - 01/2016
3	Insulin Resistance 12/2015 - 05/2010
3	Thrombophilia 08/2015 - 08/2012
3	Tuberculosis (Tuberculoses) 01/2012 - 09/2009
2	Fatigue 05/2022 - 01/2022
2	Liver Diseases (Liver Disease) 11/2020 - 01/2020
2	Acidosis 01/2020 - 08/2015
2	Hypothermia 01/2020 - 09/2013
2	Cicatrix (Scar) 01/2018 - 01/2017
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2015 - 07/2007
2	Brain Injuries (Brain Injury) 02/2015 - 07/2013
2	Traumatic Brain Injuries (Traumatic Brain Injury) 02/2015 - 07/2013
2	Human Influenza (Influenza) 01/2014 - 01/2012
1	Cognitive Dysfunction 01/2022
1	Parasitemia 01/2022
1	Type 2 Diabetes Mellitus (MODY) 06/2018
1	Hypertension (High Blood Pressure) 06/2018
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2018
1	Metabolic Diseases (Metabolic Disease) 06/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2018
1	Drug-Related Side Effects and Adverse Reactions 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Glanders 01/2016
1	Macular Degeneration (Age-Related Maculopathy) 01/2016
1	Bacterial Infections (Bacterial Infection) 12/2015
1	Disease Progression 03/2015
1	Schizophrenia (Dementia Praecox) 02/2015
1	Heat Stress Disorders (Heat Cramp) 12/2014
1	Hemorrhage 07/2014
1	Alzheimer Disease (Alzheimer's Disease) 09/2012
1	Hemophilia A (Haemophilia) 10/2011

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2005
6	Thrombin FDA Link 01/2020 - 08/2012
5	Caffeine (No Doz)FDA LinkGeneric 05/2022 - 02/2013
5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 07/2007
4	Pharmaceutical PreparationsIBA 11/2020 - 01/2012
3	Insulin (Novolin)FDA Link 06/2018 - 05/2010
3	Blood Coagulation Factors (Coagulation Factor)IBA 01/2018 - 08/2015
2	Hemostatics (Antihemorrhagics)IBA 01/2020 - 01/2018
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 09/2009
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 07/2013
2	CollagenIBA 01/2017 - 01/2017
2	Fibrinogen (Factor I)FDA Link 01/2016 - 07/2014
2	Virulence Factors (Pathogenicity Factors)IBA 01/2016 - 12/2015
2	Uridine Monophosphate (UMP)IBA 01/2016 - 06/2015
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2022
1	Terpenes (Terpenoids)IBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2020
1	Saline SolutionIBA 01/2020
1	Angiopoietin-2IBA 01/2019
1	AmmoniaIBA 01/2019
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	LipidsIBA 06/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Fibronectins (Fibronectin)IBA 01/2018
1	Thromboplastin (Tissue Factor)IBA 01/2018
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 01/2018
1	Type IV Secretion SystemsIBA 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 01/2017
1	Chloroquine (Aralen)FDA LinkGeneric 01/2017
1	prothrombin complex concentrates (PPSB)IBA 01/2016
1	FibrinIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	CytokinesIBA 01/2016
1	VaccinesIBA 01/2016
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 01/2016
1	CarbohydratesIBA 12/2015
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2015
1	Interleukin-8 (Interleukin 8)IBA 12/2015
1	Indicators and Reagents (Reagents)IBA 08/2015
1	AerosolsIBA 03/2015
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2015
1	Disks Large Homolog 4 ProteinIBA 02/2015
1	Combined VaccinesIBA 09/2014
1	Interleukin-6 (Interleukin 6)IBA 02/2014
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2012
1	UbiquitinIBA 09/2012
1	Antiviral Agents (Antivirals)IBA 01/2012
1	Neuraminidase (Sialidase)IBA 01/2012
1	Oseltamivir (Tamiflu)FDA Link 01/2012
1	Zanamivir (Relenza)FDA Link 01/2012
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 10/2011
1	Factor VIIa (Activated Factor VII)IBA 10/2011
1	Factor VII (Proconvertin)IBA 10/2011
1	SolutionsIBA 02/2011
1	EnzymesIBA 11/2010

Therapy/Procedure

3	Therapeutics 01/2019 - 07/2007
2	Resuscitation 08/2015 - 09/2013
1	Wearable Electronic Devices 01/2022
1	Hemodilution 01/2020
1	Lasers (Laser) 01/2020